Examkin

Soru

Zorluk: ZorEndocrinology and Metabolism

A 42-year-old man presents to the clinic with a 3-month history of unintended weight loss, palpitations, excessive sweating, and frequent bowel movements. He also reports experiencing new-onset, intermittent frontal headaches over the same period. He has no significant past medical history and takes no medications. Blood pressure is 145/85 mm Hg145/85 \text{ mm Hg} and pulse is 110/min110/\text{min}. Physical examination reveals a mild, diffuse enlargement of the thyroid gland without any palpable nodules. A fine resting tremor is present in both outstretched hands. Visual fields are full to confrontation.

Laboratory results are as follows:
Thyroid-stimulating hormone (TSH): 6.5 mIU/L6.5 \text{ mIU/L} (Normal: 0.4−4.2 mIU/L0.4 - 4.2 \text{ mIU/L})
Free thyroxine (T4): 3.2 ng/dL3.2 \text{ ng/dL} (Normal: 0.8−1.8 ng/dL0.8 - 1.8 \text{ ng/dL})
Free triiodothyronine (T3): 7.1 pg/mL7.1 \text{ pg/mL} (Normal: 2.3−4.2 pg/mL2.3 - 4.2 \text{ pg/mL})

Which of the following is the most appropriate next step in management?

  1. A
    Radioactive iodine uptake scan
  2. B
    Measurement of thyrotropin receptor antibodies
  3. Magnetic resonance imaging of the pituitary glandCevap
  4. D
    Initiation of methimazole therapy
  5. E
    Routine monitoring and repeat laboratory testing in 3 months

Cevap

Magnetic resonance imaging of the pituitary gland
This patient's laboratory results demonstrate an elevated free T4 and free T3 accompanied by an elevated TSH. In normal physiology, high circulating levels of thyroid hormones strongly suppress pituitary TSH production via negative feedback. The presence of an elevated or inappropriately normal TSH in the setting of thyrotoxicosis is the biochemical hallmark of central hyperthyroidism. The combination of central hyperthyroidism and new-onset headaches is highly suspicious for a TSH-secreting pituitary adenoma (TSHoma). Therefore, the most appropriate next step in management is magnetic resonance imaging of the pituitary gland. This imaging modality will identify the tumor, assess its size, and evaluate for any mass effect on adjacent structures (e.g., the optic chiasm) prior to consideration of transsphenoidal surgery or medical therapy with somatostatin analogs.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient exhibits classic signs and symptoms of thyrotoxicosis (weight loss, palpitations, tremor, sweating) along with new-onset headaches.
To establish the primary clinical syndrome and identify any focal localizing signs.
2
Interpret the thyroid function tests.
Free T4 and free T3 are elevated, biochemically confirming thyrotoxicosis. However, the TSH is paradoxically elevated rather than suppressed.
To differentiate between primary and central causes of the endocrine abnormality.
3
Synthesize findings to determine the most likely diagnosis.
Elevated thyroid hormones combined with a non-suppressed TSH indicates central hyperthyroidism. The presence of headaches further suggests a space-occupying lesion, specifically a TSH-secreting pituitary macroadenoma.
To formulate a targeted diagnostic plan.
4
Determine the most appropriate next diagnostic step.
Imaging of the pituitary gland is required to visualize the adenoma, evaluate its extent, and plan for potential surgical resection.
To definitively confirm the underlying central etiology before initiating definitive therapy.

Anahtar Kavram

Central hyperthyroidism (e.g., TSH-secreting pituitary adenoma) is characterized by elevated free T4 and T3 levels accompanied by an inappropriately normal or elevated TSH level.
Bu soruyu puanla

Konular

Endocrinology and Metabolism

Bu konudan daha fazla soru